தொழில்துறை சணல் உரிமம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொழில்துறை சணல் உரிமம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொழில்துறை சணல் உரிமம் Today - Breaking & Trending Today

Hempsana Inc. Investor Overview


Accredited Investor email list
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for accredited investor in the search bar above.
By completing this form, you are giving consent to receive communication from Hempsana using the contact information you provide. And remember you can unsubscribe at any time.
Hempsana’s Management Team
Randy Ko Co-Founder, CEO & President
Randy Ko is a management consulting executive with over 20 years of experience delivering business transformation initiatives and providing advisory services for startups across a broad spectrum of industries such as cannabis, agriculture, pharmaceutical, financial services, oil and gas, mining, retail, manufacturing and higher education. ....

United States , Adam Potts , Eurofins Experchem , Sohil Mana , Randy Ko , David Chan , Schulich School Of Business , Wilfrid Laurier University , Khiron Life Sciences , Versapay Corp Tsxv , European Union , Hempsana Premier Services , Health Canada , Hempsana Management Team , Hempsana Company , Business Development , Quality Extraction , Rare Cannabinoids , Active Pharmaceutical Ingredients , Industrial Hemp License , Standard Processing License , South America , Investor Kit , Canbud Distribution , Key Products , Quality Assurance ,

Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.


Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.
Company or
Canntab ), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its 2
nd (second) delivery of (2) (two) additional SKU s ordered by MediPharm Labs Corp ( MediPharm Labs ) (TSX: LABS) (OTCQX: MEDIF) including 12.5mg CBD caplets (hard tablets in the shape of capsules) and 25mg CBD caplets for approximately $550,000.00. Canntab has now fulfilled 80% of the purchase amount contracted under the wholesale table purchase agreement entered into by the Company and MediPharm Labs in June, 2020. ....

United States , Frank Candido , Larry Latowsky , Canntab Therapeutics Inc , Company Or Canntab , Canntab Therapeutics Limited , Canntab Therapeutics Limited Larry Latowsky , Canntab Therapeutics Limited Richard Goldstein , Cannabis Research Licence , Neither The Canadian Securities Exchange , Clinical Research Organization , Medipharm Labs Corp , Canadian Securities Exchange , Frankfurt Stock Exchange , Newsfile Corp , Investor Relations Canntab Therapeutics , Health Canada , Business Development , Therapeutics Limited , Medipharm Labs , Chief Executive Officer , Canntab Therapeutics , Canadian Licensed Producer , Cannabis Standard Processing , Medical Purposes Licence , Industrial Hemp Licence ,